Armistice Capital, LLC 13D/13G Filings for Skye Bioscience, Inc. (SKYE)

Armistice Capital, LLC 13D and 13G filings for Skye Bioscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
5:29 pm
Purchase
2020-12-31 13G Skye Bioscience, Inc.
SKYE
Armistice Capital, LLC 50,413
4.990%
50,413increase
(New Position)
Filing